Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.96%73.420.9%$713.07m
AMGNAmgen Inc.
0.08%179.321.1%$583.83m
CELGCelgene Corporation
0.97%136.311.1%$571.96m
REGNRegeneron Pharmaceuticals, Inc.
2.83%521.132.7%$511.51m
VRTXVertex Pharmaceuticals Incorporated
-0.23%159.331.9%$392.76m
BIIBBiogen Inc.
-0.18%281.441.2%$388.90m
ALXNAlexion Pharmaceuticals, Inc.
1.97%129.811.9%$272.80m
TSROTESARO, Inc.
4.02%129.0114.7%$168.19m
INCYIncyte Corporation
2.56%133.792.6%$164.97m
ILMNIllumina, Inc.
-1.10%171.973.5%$156.83m
EXELExelixis, Inc.
0.90%26.996.5%$154.24m
CLVSClovis Oncology, Inc.
1.69%85.2718.0%$152.78m
BMRNBioMarin Pharmaceutical Inc.
0.59%87.744.4%$131.34m
KITEKite Pharma, Inc.
4.23%109.8916.1%$121.79m
BLUEBluebird Bio, Inc.
-1.54%95.8019.3%$109.71m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.